{"count": 13, "results": [{"_id": "32210573", "pmid": 32210573, "pmcid": "PMC7074824", "title": "Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and beta-Catenin Signaling", "journal": "Onco Targets Ther", "authors": ["Liu Q", "Xia H", "Zhou S", "Tang Q", "Zhou J", "Ren M", "Bi F"], "date": "2020-03-09T00:00:00Z", "doi": "10.2147/OTT.S237693", "meta_date_publication": "2020", "meta_volume": "13", "meta_issue": "", "meta_pages": "2057-2066", "score": 50266.812, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ could inhibit proliferation, migration and invasion, and promote the apoptosis in @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@gastric cancer@@@ cells. ", "citations": {"NLM": "Liu Q, Xia H, Zhou S, Tang Q, Zhou J, Ren M, Bi F. Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and beta-Catenin Signaling Onco Targets Ther. 2020;13():2057-2066. PMID: 32210573", "BibTeX": "@article{32210573, title={Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and beta-Catenin Signaling}, author={Liu Q and Xia H and Zhou S and Tang Q and Zhou J and Ren M and Bi F}, journal={Onco Targets Ther}, volume={13}, pages={2057-2066}}"}}, {"_id": "31964553", "pmid": 31964553, "title": "TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer.", "journal": "Pathol Res Pract", "authors": ["Hong JY", "Kim HJ", "Kim K", "Hong J", "Kim JE", "Byeon SJ", "Lee IK", "Kim KM", "Shim M", "Park SH", "Park JO", "Park YS", "Lim HY", "Kim ST", "Lee J", "Kang WK"], "date": "2020-03-01T00:00:00Z", "doi": "10.1016/j.prp.2020.152820", "meta_date_publication": "2020 Mar", "meta_volume": "216", "meta_issue": "3", "meta_pages": "152820", "score": 50259.453, "text_hl": "@GENE_TPK1 @GENE_27010 @@@TPK1@@@ as a predictive marker for the anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@gastric cancer@@@.", "citations": {"NLM": "Hong JY, Kim HJ, Kim K, Hong J, Kim JE, Byeon SJ, Lee IK, Kim KM, Shim M, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee J, Kang WK. TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer. Pathol Res Pract. 2020 Mar;216(3):152820. PMID: 31964553", "BibTeX": "@article{31964553, title={TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer.}, author={Hong JY and Kim HJ and Kim K and Hong J and Kim JE and Byeon SJ and Lee IK and Kim KM and Shim M and Park SH and Park JO and Park YS and Lim HY and Kim ST and Lee J and Kang WK}, journal={Pathol Res Pract}, volume={216}, number={3}, pages={152820}}"}}, {"_id": "33093924", "pmid": 33093924, "pmcid": "PMC7573883", "title": "Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer", "journal": "Oncol Lett", "authors": ["Ortiz N", "Díaz C"], "date": "2020-12-01T00:00:00Z", "doi": "10.3892/ol.2020.12183", "meta_date_publication": "2020 Dec", "meta_volume": "20", "meta_issue": "6", "meta_pages": "320", "score": 50259.04, "text_hl": "Preliminary results from our group on primary @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@gastric tumor@@@ cells indicated a similar level of sensitivity to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ as @CELLLINE_CVCL:0333 @@@Hs746T@@@ cells (data not shown).", "citations": {"NLM": "Ortiz N, Díaz C. Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer Oncol Lett. 2020 Dec;20(6):320. PMID: 33093924", "BibTeX": "@article{33093924, title={Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer}, author={Ortiz N and Díaz C}, journal={Oncol Lett}, volume={20}, number={6}, pages={320}}"}}, {"_id": "35517821", "pmid": 35517821, "pmcid": "PMC9065610", "title": "Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis", "journal": "Front Pharmacol", "authors": ["Xia Y", "Jin Y", "Cui D", "Wu X", "Song C", "Jin W", "Huang H"], "date": "2022-04-20T00:00:00Z", "doi": "10.3389/fphar.2022.860546", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "860546", "score": 50257.793, "text_hl": "Antitumor Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in Combination With @GENE_DNMT1 @GENE_1786 @@@DNA Methyltransferase@@@ Inhibitor on @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@Gastric Cancer@@@ via GSDME-Mediated Pyroptosis", "citations": {"NLM": "Xia Y, Jin Y, Cui D, Wu X, Song C, Jin W, Huang H. Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis Front Pharmacol. 2022;13():860546. PMID: 35517821", "BibTeX": "@article{35517821, title={Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis}, author={Xia Y and Jin Y and Cui D and Wu X and Song C and Jin W and Huang H}, journal={Front Pharmacol}, volume={13}, pages={860546}}"}}, {"_id": "39317047", "pmid": 39317047, "title": "Simvastatin induces ferroptosis and activates anti-tumor immunity to sensitize anti-PD-1 immunotherapy in microsatellite stable gastric cancer.", "journal": "Int Immunopharmacol", "authors": ["Ning Y", "Fang S", "Zhang R", "Fang J", "Lin K", "Ding Y", "Nie H", "Zhou J", "Zhao Q", "Ke H", "Wang H", "Wang F"], "date": "2024-09-23T00:00:00Z", "doi": "10.1016/j.intimp.2024.113244", "meta_date_publication": "2024 Sep 23", "meta_volume": "142", "meta_issue": "Pt B", "meta_pages": "113244", "score": 50255.75, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induces ferroptosis and activates anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ immunity to sensitize anti-@GENE_PDCD1 @GENE_5133 @@@PD-1@@@ immunotherapy in microsatellite stable @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@gastric cancer@@@.", "citations": {"NLM": "Ning Y, Fang S, Zhang R, Fang J, Lin K, Ding Y, Nie H, Zhou J, Zhao Q, Ke H, Wang H, Wang F. Simvastatin induces ferroptosis and activates anti-tumor immunity to sensitize anti-PD-1 immunotherapy in microsatellite stable gastric cancer. Int Immunopharmacol. 2024 Sep 23;142(Pt B):113244. PMID: 39317047", "BibTeX": "@article{39317047, title={Simvastatin induces ferroptosis and activates anti-tumor immunity to sensitize anti-PD-1 immunotherapy in microsatellite stable gastric cancer.}, author={Ning Y and Fang S and Zhang R and Fang J and Lin K and Ding Y and Nie H and Zhou J and Zhao Q and Ke H and Wang H and Wang F}, journal={Int Immunopharmacol}, volume={142}, number={Pt B}, pages={113244}}"}}, {"_id": "34103960", "pmid": 34103960, "pmcid": "PMC8180305", "title": "Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells", "journal": "Clin Exp Gastroenterol", "authors": ["Ortiz N", "Delgado-Carazo JC", "Díaz C"], "date": "2021-05-31T00:00:00Z", "doi": "10.2147/CEG.S310235", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "217-228", "score": 50242.13, "text_hl": "...IC50 Values of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in Primary (@GENE_JAG1 @GENE_182 @@@AGS@@@) and Metastatic (@CELLLINE_CVCL:1603 @@@NCI-N87@@@) @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@Gastric Cancer@@@ Cell Lines", "citations": {"NLM": "Ortiz N, Delgado-Carazo JC, Díaz C. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells Clin Exp Gastroenterol. 2021;14():217-228. PMID: 34103960", "BibTeX": "@article{34103960, title={Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells}, author={Ortiz N and Delgado-Carazo JC and Díaz C}, journal={Clin Exp Gastroenterol}, volume={14}, pages={217-228}}"}}, {"_id": "39227585", "pmid": 39227585, "title": "PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis.", "journal": "Cell Death Dis", "authors": ["Wang X", "Liu Y", "Zhao Q", "Wang X", "Chen X", "Hou L", "Tian S", "Peng ZM", "Han XJ", "Wang T", "Zhang Z", "Tou FF", "Huang S", "Rao J", "Chen L", "Zheng Z"], "date": "2024-09-03T00:00:00Z", "doi": "10.1038/s41419-024-07026-5", "meta_date_publication": "2024 Sep 3", "meta_volume": "15", "meta_issue": "9", "meta_pages": "642", "score": 50240.45, "text_hl": "Taken together, our findings illustrate that the oncogenic role of @GENE_PILRB @GENE_29990 @@@PILRB@@@ in @DISEASE_Carcinogenesis @DISEASE_MESH:D063646 @@@gastric tumorigenesis@@@, providing new insights into the regulation of @GENE_PIK3CD @GENE_5293 @@@PI3K@@@/@GENE_AKT1 @GENE_207 @@@AKT@@@ signaling in @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@GC@@@ and establishing @GENE_PILRB @GENE_29990 @@@PILRB@@@ as a biomarker for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy resistance in @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@GC@@@.", "citations": {"NLM": "Wang X, Liu Y, Zhao Q, Wang X, Chen X, Hou L, Tian S, Peng ZM, Han XJ, Wang T, Zhang Z, Tou FF, Huang S, Rao J, Chen L, Zheng Z. PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis. Cell Death Dis. 2024 Sep 3;15(9):642. PMID: 39227585", "BibTeX": "@article{39227585, title={PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis.}, author={Wang X and Liu Y and Zhao Q and Wang X and Chen X and Hou L and Tian S and Peng ZM and Han XJ and Wang T and Zhang Z and Tou FF and Huang S and Rao J and Chen L and Zheng Z}, journal={Cell Death Dis}, volume={15}, number={9}, pages={642}}"}}, {"_id": "26277021", "pmid": 26277021, "title": "Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor.", "journal": "Int J Radiat Oncol Biol Phys", "authors": ["Lim T", "Lee I", "Kim J", "Kang WK"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/j.ijrobp.2015.05.023", "meta_date_publication": "2015 Oct 1", "meta_volume": "93", "meta_issue": "2", "meta_pages": "316-25", "score": 50056.652, "text_hl": "Synergistic Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Plus Radiation in @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@Gastric Cancer@@@ and @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@Colorectal Cancer@@@: Implications of @GENE_BIRC5 @GENE_332 @@@BIRC5@@@ and Connective Tissue Growth Factor.", "citations": {"NLM": "Lim T, Lee I, Kim J, Kang WK. Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor. Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):316-25. PMID: 26277021", "BibTeX": "@article{26277021, title={Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor.}, author={Lim T and Lee I and Kim J and Kang WK}, journal={Int J Radiat Oncol Biol Phys}, volume={93}, number={2}, pages={316-25}}"}}, {"_id": "25218337", "pmid": 25218337, "title": "Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study.", "journal": "Eur J Cancer", "authors": ["Kim ST", "Kang JH", "Lee J", "Park SH", "Park JO", "Park YS", "Lim HY", "Hwang IG", "Lee SC", "Park KW", "Lee HR", "Kang WK"], "date": "2014-11-01T00:00:00Z", "doi": "10.1016/j.ejca.2014.08.005", "meta_date_publication": "2014 Nov", "meta_volume": "50", "meta_issue": "16", "meta_pages": "2822-30", "score": 50053.848, "text_hl": "Low dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (40 mg) to chemotherapy is not recommended in untargeted population with @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@AGC@@@.", "citations": {"NLM": "Kim ST, Kang JH, Lee J, Park SH, Park JO, Park YS, Lim HY, Hwang IG, Lee SC, Park KW, Lee HR, Kang WK. Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study. Eur J Cancer. 2014 Nov;50(16):2822-30. PMID: 25218337", "BibTeX": "@article{25218337, title={Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study.}, author={Kim ST and Kang JH and Lee J and Park SH and Park JO and Park YS and Lim HY and Hwang IG and Lee SC and Park KW and Lee HR and Kang WK}, journal={Eur J Cancer}, volume={50}, number={16}, pages={2822-30}}"}}, {"_id": "24233024", "pmid": 24233024, "title": "Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.", "journal": "J Mol Med (Berl)", "authors": ["Manu KA", "Shanmugam MK", "Li F", "Chen L", "Siveen KS", "Ahn KS", "Kumar AP", "Sethi G"], "date": "2014-03-01T00:00:00Z", "doi": "10.1007/s00109-013-1095-0", "meta_date_publication": "2014 Mar", "meta_volume": "92", "meta_issue": "3", "meta_pages": "267-76", "score": 50053.8, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ sensitizes @SPECIES_9606 @@@human@@@ @<m>DISEASE_Stomach_Neoplasms</m> @DISEASE_MESH:D013274 @@@gastric cancer@@@ xenograft in nude @SPECIES_10090 @@@mice@@@ to @CHEMICAL_Capecitabine @CHEMICAL_MESH:D000069287 @@@capecitabine@@@ by suppressing nuclear factor-kappa B-regulated gene products.", "citations": {"NLM": "Manu KA, Shanmugam MK, Li F, Chen L, Siveen KS, Ahn KS, Kumar AP, Sethi G. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products. J Mol Med (Berl). 2014 Mar;92(3):267-76. PMID: 24233024", "BibTeX": "@article{24233024, title={Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.}, author={Manu KA and Shanmugam MK and Li F and Chen L and Siveen KS and Ahn KS and Kumar AP and Sethi G}, journal={J Mol Med (Berl)}, volume={92}, number={3}, pages={267-76}}"}}]}